Cellectis S.A. current report, Q3 FY2022

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, for the month of September 2022. The filing serves to distribute a press release dated September 1, 2022, to U.S. investors.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a cover sheet referencing an external press release and does not contain embedded financial statements or quantitative performance data.

Material Changes

No material changes versus the prior comparable period are detailed in the provided text. The content is limited to the filing mechanics and the reference to the attached press release.

Guidance, Outlook, and Risks

The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.

Key Facts for Investor Verification

  • Verify the content of the press release dated September 1, 2022, referenced as Exhibit 99.1, as the filing itself contains no operational or financial data.
  • Confirm the company's status as a registrant filing under Form 20-F.
  • Note that the Chief Executive Officer, André Choulika, signed the report on September 1, 2022.